search
Back to results

Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments (SILVER NA)

Primary Purpose

COVID-19 Pandemic, Professional Stress

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Questionnaire
Sponsored by
Centre Hospitalier Charles Perrens, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for COVID-19 Pandemic focused on measuring COVID-19, Health Professionals, Psychological troubles, Health institution

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Be aged 18 and over,
  • Have given their consent to participate in the study,
  • Work in an accommodation establishment for the elderly or professional home help in New Aquitaine.
  • Master the French language.
  • Accept online reviews
  • Be a beneficiary of health insurance

Exclusion Criteria:

  • Bad understanding of instructions making consent or assessment impossible
  • Refusal to participate
  • Be under measure of legal protection: guardianship, trusteeship or safeguard of justice

Sites / Locations

  • Centre Hospitalier Charles Perrens

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Epidemiology

Arm Description

Participants will answer sociodemographic questions, questions about the experience of potentially traumatic lifelong events, the presence of a known psychological or medical disorder and the taking of drug treatment. These questionnaires will make it possible to detect the main psychological disorders (post-traumatic stress disorder, depression, panic disorder, generalized anxiety disorder), to evaluate coping strategies, the presence of professional exhaustion (burnout), the consumption of psychoactive substances and quality of life.

Outcomes

Primary Outcome Measures

Prevalence of anxiety disorders
The appearance of symptoms of anxiety disorders measured through the General Anxiety Disorder-7 questionnaire A total score greater than 7 should lead to the hypothesis of a generalized anxiety disorder. A total score between 5 and 9 corresponds to mild anxiety, a score of 10 to 14 corresponds to moderate anxiety and a score above 15 corresponds to severe anxiety.
Prevalence of anxiety disorders
The appearance of symptoms of anxiety disorders measured through the Panic Disorder Self-Report questionnaire. This questionnaire is a 24-item self-report measure designed to diagnose panic disorder based on Diagnostic and Statistical Manual-IV and Diagnostic and Statistical Manual-V criteria. Most of items are answered in a simple Yes/No fashion. Nevertheless, there are also some questions, for example about severity, which are answered on 5-point Likert scales. Not all of the questions have to be answered by every patient. If a panic disorder can already be excluded, the questionnaire stops.

Secondary Outcome Measures

Measure the prevalence of post-traumatic stress disorder
Participants will answer the Posttraumatic stress disorder Checklist which is a questionnaire allowing the screening of post-traumatic stress disorder. Min=0 max=80 Higher score mean a worse outcome
Measure the prevalence of depressive episodes
Participants will answer the Beck Depression Inventory- Fast Screen which is the questionnaire for screening for major depressive disorder Min = 0 Max =21 Higher score mean a worse outcome
Measure the prevalence of depressive episodes
Participants will answer the Coping Inventory for Stressful Situations which is the scale assesses the 4 types of coping strategies (emotion-focused, support-focused, problem-focused, avoidance-focused ). There are three sub-scales : Task oriented min=0 max=56 Emotional oriented min=0 max =42 Avoidance oreinted min =0 max =51
Study the professional burnout syndrome
Participants will answer the Maslach Burnout Inventory which is the questionnaire allowing the screening of a burn-out. There are three sub-scales : Burnout score min =0 max =54 Depersonalization score / Loss of empathy min =0 max=30 For these two subscales: Higher scores mean a worse outcome Personal Achievement Score min = 0 max=48 For this subscale: Higher score mean a better outcome
Study the the quality of life at work among staff
Participants will answer the Medical Outcomes Study Short-Form which is the questionnaire to assess the quality of life Min=0 max=100 Higher score mean a better outcome
Study the use of psychostimulant substances (drugs, alcohol, drugs, tobacco) among the staff of accommodation facilities for old people and home help
The consumption of psychoactive substances will be assessed through a multiple-choice menu, allowing to tick the substances consumed by the participant during the last month. The categories of psychoactive substances are: anxiolytics and sedatives (eg benzodiazepines, hypnotics etc), psycho-stimulants (eg cocaine, amphetamines, ecstasy etc), opiates and related drugs (eg codeine, heroin etc), cannabis, alcohol and tobacco. According to the items, the person will indicate for each psychoactive substance checked the level of consumption (absent, new, increasing, constant).

Full Information

First Posted
May 6, 2022
Last Updated
July 19, 2022
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT05381883
Brief Title
Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments
Acronym
SILVER NA
Official Title
Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 15, 2022 (Anticipated)
Primary Completion Date
November 30, 2022 (Anticipated)
Study Completion Date
November 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Charles Perrens, Bordeaux

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is identify the psychological impact of the coronavirus-19 pandemic on professionals in residential care facilities for old people and home help professionals in New-Aquitaine by : Large-scale screening for the prevalence of mental health disorders among staff. Identification of vulnerability and resilience factors. Improving access to early care for affected professionals.
Detailed Description
This is a repeated cross-sectional descriptive study with two independent collection points six months apart, using socio-economic self-questionnaires and psychometric scales, which aims to measure the incidence of psychological disorders. This study included the completion of questionnaires in a non-clinical population. This is a study aimed at describing a profile of psychological condition in adults.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19 Pandemic, Professional Stress
Keywords
COVID-19, Health Professionals, Psychological troubles, Health institution

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Epidemiology
Arm Type
Other
Arm Description
Participants will answer sociodemographic questions, questions about the experience of potentially traumatic lifelong events, the presence of a known psychological or medical disorder and the taking of drug treatment. These questionnaires will make it possible to detect the main psychological disorders (post-traumatic stress disorder, depression, panic disorder, generalized anxiety disorder), to evaluate coping strategies, the presence of professional exhaustion (burnout), the consumption of psychoactive substances and quality of life.
Intervention Type
Other
Intervention Name(s)
Questionnaire
Intervention Description
Participants will answer socio-demographic questions, questions about the lifetime experience of potentially traumatic events, the presence of a known psychological or medical disorder and the taking of medication, and a series of psychological assessment questionnaires. The questionnaires, performed outside routine care, are as follows : Posttraumatic stress disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 Beck Depression Inventory-Fast Screen General Anxiety Disorder-7 Coping Inventory for Stressful Situations Maslach Burnout Inventory Medical Outcomes Study Short-Form The total time for completing the questionnaires is estimated at 20 minutes
Primary Outcome Measure Information:
Title
Prevalence of anxiety disorders
Description
The appearance of symptoms of anxiety disorders measured through the General Anxiety Disorder-7 questionnaire A total score greater than 7 should lead to the hypothesis of a generalized anxiety disorder. A total score between 5 and 9 corresponds to mild anxiety, a score of 10 to 14 corresponds to moderate anxiety and a score above 15 corresponds to severe anxiety.
Time Frame
Baseline
Title
Prevalence of anxiety disorders
Description
The appearance of symptoms of anxiety disorders measured through the Panic Disorder Self-Report questionnaire. This questionnaire is a 24-item self-report measure designed to diagnose panic disorder based on Diagnostic and Statistical Manual-IV and Diagnostic and Statistical Manual-V criteria. Most of items are answered in a simple Yes/No fashion. Nevertheless, there are also some questions, for example about severity, which are answered on 5-point Likert scales. Not all of the questions have to be answered by every patient. If a panic disorder can already be excluded, the questionnaire stops.
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Measure the prevalence of post-traumatic stress disorder
Description
Participants will answer the Posttraumatic stress disorder Checklist which is a questionnaire allowing the screening of post-traumatic stress disorder. Min=0 max=80 Higher score mean a worse outcome
Time Frame
Baseline
Title
Measure the prevalence of depressive episodes
Description
Participants will answer the Beck Depression Inventory- Fast Screen which is the questionnaire for screening for major depressive disorder Min = 0 Max =21 Higher score mean a worse outcome
Time Frame
Baseline
Title
Measure the prevalence of depressive episodes
Description
Participants will answer the Coping Inventory for Stressful Situations which is the scale assesses the 4 types of coping strategies (emotion-focused, support-focused, problem-focused, avoidance-focused ). There are three sub-scales : Task oriented min=0 max=56 Emotional oriented min=0 max =42 Avoidance oreinted min =0 max =51
Time Frame
Baseline
Title
Study the professional burnout syndrome
Description
Participants will answer the Maslach Burnout Inventory which is the questionnaire allowing the screening of a burn-out. There are three sub-scales : Burnout score min =0 max =54 Depersonalization score / Loss of empathy min =0 max=30 For these two subscales: Higher scores mean a worse outcome Personal Achievement Score min = 0 max=48 For this subscale: Higher score mean a better outcome
Time Frame
Baseline
Title
Study the the quality of life at work among staff
Description
Participants will answer the Medical Outcomes Study Short-Form which is the questionnaire to assess the quality of life Min=0 max=100 Higher score mean a better outcome
Time Frame
Baseline
Title
Study the use of psychostimulant substances (drugs, alcohol, drugs, tobacco) among the staff of accommodation facilities for old people and home help
Description
The consumption of psychoactive substances will be assessed through a multiple-choice menu, allowing to tick the substances consumed by the participant during the last month. The categories of psychoactive substances are: anxiolytics and sedatives (eg benzodiazepines, hypnotics etc), psycho-stimulants (eg cocaine, amphetamines, ecstasy etc), opiates and related drugs (eg codeine, heroin etc), cannabis, alcohol and tobacco. According to the items, the person will indicate for each psychoactive substance checked the level of consumption (absent, new, increasing, constant).
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Be aged 18 and over, Have given their consent to participate in the study, Work in an accommodation establishment for the elderly or professional home help in New Aquitaine. Master the French language. Accept online reviews Be a beneficiary of health insurance Exclusion Criteria: Bad understanding of instructions making consent or assessment impossible Refusal to participate Be under measure of legal protection: guardianship, trusteeship or safeguard of justice
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Charles-Henry MARTIN, MD
Phone
05 56 56 31 30
Email
cmartin@ch-perrens.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Helen SAVARIEAU
Phone
05 56 56 35 56
Email
hsavarieau@ch-perrens.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charles-Henry MARTIN, MD
Organizational Affiliation
Physician
Official's Role
Study Director
Facility Information:
Facility Name
Centre Hospitalier Charles Perrens
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Charles-Martin MARTIN, MD
Phone
05 56 56 31 30
Email
cmartin@ch-perrens.fr

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26544738
Citation
Mohammed A, Sheikh TL, Poggensee G, Nguku P, Olayinka A, Ohuabunwo C, Eaton J. Mental health in emergency response: lessons from Ebola. Lancet Psychiatry. 2015 Nov;2(11):955-7. doi: 10.1016/S2215-0366(15)00451-4. No abstract available.
Results Reference
result
PubMed Identifier
15133143
Citation
Chan AO, Huak CY. Psychological impact of the 2003 severe acute respiratory syndrome outbreak on health care workers in a medium size regional general hospital in Singapore. Occup Med (Lond). 2004 May;54(3):190-6. doi: 10.1093/occmed/kqh027.
Results Reference
result
PubMed Identifier
15283533
Citation
Chua SE, Cheung V, McAlonan GM, Cheung C, Wong JW, Cheung EP, Chan MT, Wong TK, Choy KM, Chu CM, Lee PW, Tsang KW. Stress and psychological impact on SARS patients during the outbreak. Can J Psychiatry. 2004 Jun;49(6):385-90. doi: 10.1177/070674370404900607.
Results Reference
result
PubMed Identifier
3655778
Citation
Csikszentmihalyi M, Larson R. Validity and reliability of the Experience-Sampling Method. J Nerv Ment Dis. 1987 Sep;175(9):526-36. doi: 10.1097/00005053-198709000-00004.
Results Reference
result
PubMed Identifier
32217624
Citation
Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ. 2020 Mar 26;368:m1211. doi: 10.1136/bmj.m1211. No abstract available.
Results Reference
result

Learn more about this trial

Mental Health of Professionals of the Silver Economy of New Aquitaine : Online Survey of Accommodation Establishments for Old People and Home Assistance Establishments

We'll reach out to this number within 24 hrs